Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 10 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005840 | ribosome | 5 | 8 |
GO:0043226 | organelle | 2 | 8 |
GO:0043228 | non-membrane-bounded organelle | 3 | 8 |
GO:0043229 | intracellular organelle | 3 | 8 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
GO:0005829 | cytosol | 2 | 1 |
Related structures:
AlphaFold database: E9B674
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 39 | 43 | PF00656 | 0.512 |
CLV_PCSK_SKI1_1 | 73 | 77 | PF00082 | 0.267 |
DOC_CKS1_1 | 161 | 166 | PF01111 | 0.576 |
DOC_CYCLIN_yCln2_LP_2 | 125 | 131 | PF00134 | 0.492 |
DOC_PP2B_LxvP_1 | 125 | 128 | PF13499 | 0.561 |
DOC_PP4_FxxP_1 | 133 | 136 | PF00568 | 0.467 |
DOC_PP4_FxxP_1 | 64 | 67 | PF00568 | 0.365 |
DOC_USP7_MATH_1 | 45 | 49 | PF00917 | 0.516 |
DOC_USP7_UBL2_3 | 73 | 77 | PF12436 | 0.561 |
DOC_WW_Pin1_4 | 160 | 165 | PF00397 | 0.524 |
LIG_Actin_WH2_2 | 53 | 71 | PF00022 | 0.365 |
LIG_AP2alpha_2 | 135 | 137 | PF02296 | 0.467 |
LIG_BRCT_BRCA1_1 | 60 | 64 | PF00533 | 0.492 |
LIG_BRCT_BRCA1_1 | 94 | 98 | PF00533 | 0.467 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.504 |
LIG_FHA_1 | 111 | 117 | PF00498 | 0.475 |
LIG_FHA_1 | 174 | 180 | PF00498 | 0.589 |
LIG_FHA_1 | 74 | 80 | PF00498 | 0.496 |
LIG_FHA_2 | 105 | 111 | PF00498 | 0.474 |
LIG_FHA_2 | 161 | 167 | PF00498 | 0.576 |
LIG_LIR_Apic_2 | 61 | 67 | PF02991 | 0.365 |
LIG_LIR_Gen_1 | 95 | 102 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 95 | 101 | PF02991 | 0.460 |
LIG_MLH1_MIPbox_1 | 94 | 98 | PF16413 | 0.467 |
LIG_NRBOX | 74 | 80 | PF00104 | 0.561 |
LIG_PDZ_Class_1 | 179 | 184 | PF00595 | 0.642 |
LIG_Pex14_2 | 133 | 137 | PF04695 | 0.467 |
LIG_SH2_STAT5 | 74 | 77 | PF00017 | 0.492 |
LIG_SH2_STAT5 | 97 | 100 | PF00017 | 0.449 |
LIG_SH3_3 | 158 | 164 | PF00018 | 0.526 |
LIG_TRAF2_1 | 107 | 110 | PF00917 | 0.467 |
LIG_TRAF2_1 | 163 | 166 | PF00917 | 0.526 |
MOD_CK2_1 | 104 | 110 | PF00069 | 0.467 |
MOD_CK2_1 | 160 | 166 | PF00069 | 0.492 |
MOD_CK2_1 | 172 | 178 | PF00069 | 0.472 |
MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.332 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.273 |
MOD_GSK3_1 | 116 | 123 | PF00069 | 0.542 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.563 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.496 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.563 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.561 |
MOD_PIKK_1 | 149 | 155 | PF00454 | 0.365 |
MOD_Plk_1 | 79 | 85 | PF00069 | 0.492 |
MOD_Plk_4 | 110 | 116 | PF00069 | 0.469 |
MOD_Plk_4 | 80 | 86 | PF00069 | 0.482 |
MOD_ProDKin_1 | 160 | 166 | PF00069 | 0.524 |
TRG_ENDOCYTIC_2 | 97 | 100 | PF00928 | 0.460 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3G1 | Leptomonas seymouri | 73% | 88% |
A0A0S4JL27 | Bodo saltans | 48% | 81% |
A0A1X0P641 | Trypanosomatidae | 46% | 88% |
A0A3Q8IHY8 | Leishmania donovani | 96% | 87% |
A4IB94 | Leishmania infantum | 96% | 87% |
E9AF18 | Leishmania major | 93% | 100% |
P48636 | Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) | 28% | 94% |